News for Ambrx Biopharma Inc Stock (AMAM) ; FDA Grants Fast Track Designation for Ambrx's ARX for the Treatment of Metastatic Castration-Resistant Prostate. Get the LIVE share price of Ambrx Biopharma(AMAM) and stock performance in one place to strengthen your trading strategy in US stocks. News for Ambrx Biopharma Inc Stock (AMAM) · Ambrx Shareholders Approve Acquisition by Johnson & Johnson · 3 Stocks to Buy That Are Up % or More in · Is. Ambrx Biopharma's current share price is $ This constitutes a share price movement of % when compared to its closing share price of $ seven days. Check if AMAM Stock has a Buy or Sell Evaluation. AMAM Stock Price (NYSE), Forecast, Predictions, Stock Analysis and Ambrx Biopharma Inc. News.
Intraday Ambrx Biopharma Chart ; Bid Price, Offer Price. ; High Price, Low Price ; Shares Traded, Last Trade. 0. Ambrx Biopharma Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing antibody drug conjugates (ADCs) and other engineered. The Ambrx Biopharma Inc ADR stock price today is What Is the Stock Symbol for Ambrx Biopharma Inc ADR? The stock ticker symbol for Ambrx Biopharma Inc. Webull offers Ambrx Biopharma Inc (AMAM) historical stock prices, in-depth market analysis, NASDAQ: AMAM real-time stock quote data, in-depth charts. The average one-year price target for Ambrx Biopharma Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price target. Track Ambrx Biopharma (AMAM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Ambrx Biopharma Inc is a clinical-stage biologics company focused on discovering and developing a novel class of engineered precision biologics (EPBs) using. Ambrx Biopharma Inc. market cap history and chart from to AMAM was delisted stock price by the number of shares outstanding. End of Day Stock Quote. Submit Sign Up. Unsubscribe. Email Alert Sign Up Confirmation. Copyright © Ambrx. All Rights Reserved | Privacy | Site Map | Terms. A high-level overview of Ambrx Biopharma Inc. (AMAM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and.
Ambrx Biopharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing antibody drug conjugates (ADCs) and. Ambrx Shareholders Approve Acquisition by Johnson & Johnson. 01/08/ Ambrx Announces Sale to Johnson & Johnson. 12/14/ Ambrx to be Added to the NASDAQ. Ambrx Biopharma Inc. (US:AMAM) has 15 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). Ambrx Biopharma Inc., a clinical stage biopharmaceutical company, focuses on discovering and All stock prices are updated at the end of the day. Real-time Price Updates for Ambrx Biopharma Inc ADR (AMAM-Q), along with buy or sell indicators, analysis, charts, historical performance, news and more. Get the latest stock price for Ambrx Biopharma Inc. (AMAM:US), plus the latest news, recent trades, charting, insider activity, and analyst ratings. The latest closing stock price for Ambrx Biopharma Inc. on March 06, is The all-time high Ambrx Biopharma Inc. closing stock. Ambrx Biopharma, Inc. (AMAM) has entered into a definitive agreement with Johnson & Johnson for acquisition at $ per share in cash, representing an. Ambrx Biopharma is the latest cancer-drug specialist to be bought by a larger pharma over the past year.
Ambrx Biopharma Inc - ADR Similar Stocks ; Clean Harbors, Inc. · · (%) · ; Water Inc · · (%) · ; Lobo Ev Technologies. In the current month, AMAM has received 10 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. AMAM average Analyst price target in the past 3 months is $ Real time Ambrx Biopharma (AMAM) stock price quote, stock graph, news & analysis. News of NEW AMBRX BIOPHARMA INC(NASDAQ:AMAM) stock. Latest News and Press releases. Ambrx Biopharma American Valuation · Delisted. USA. At this time, the firm appears to be overvalued. Ambrx Biopharma American shows a prevailing Real Value.
Ambrx (NYSE: AMAM) Rings The Closing Bell®